Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,344 Cr
down ₹8.4 Cr vs Mar 2024
- Stocks held
- 26
- unchanged
- Top 10 weight
- 69.1%
- of the portfolio in its ten largest
- Cash & debt
- 1.0%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 11
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In April 2024 it disclosed 26 stocks worth ₹2,344 Cr, down ₹8.4 Cr from Mar 2024. Its largest positions were Sun Pharmaceutical Industries Limited (13.1%), IPCA Laboratories Limited (9.2%), Suven Pharmaceuticals Limited (8.2%); the ten largest together made up 69.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 71.6% of its equity. Cash and debt stood at 1.0%. Compared with Mar 2024 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
10%
Holds more stocks than 10% of peers
Cash
12%
Holds more cash than 12% of peers
What these mean: concentration · cash
Holdings in April 2024
Download CSVEvery line the fund disclosed, with the change against Mar 2024. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 13.06% | down 0.98 pts | ₹306 Cr | down ₹24.1 Cr | Trimmed |
| IPCA Laboratories Limited | 9.17% | up 0.73 pts | ₹215 Cr | up ₹16.4 Cr | Added |
| Suven Pharmaceuticals Limited | 8.15% | down 0.18 pts | ₹191 Cr | down ₹4.8 Cr | Trimmed |
| Lupin Limited | 7.67% | up 0.16 pts | ₹180 Cr | up ₹3.2 Cr | Added |
| Cipla Limited | 7.67% | down 0.50 pts | ₹180 Cr | down ₹12.4 Cr | Trimmed |
| Alembic Pharmaceuticals Limited | 6.07% | up 0.14 pts | ₹142 Cr | up ₹2.9 Cr | Added |
| Apollo Hospitals Enterprise Limited | 4.72% | down 0.31 pts | ₹111 Cr | down ₹7.6 Cr | Trimmed |
| Concord Biotech Limited | 4.44% | up 0.40 pts | ₹104 Cr | up ₹9.1 Cr | Added |
| Zydus Lifesciences Limited | 4.22% | up 0.68 pts | ₹98.9 Cr | up ₹15.7 Cr | Added |
| Globus Medical Inc | 3.94% | down 0.28 pts | ₹92.3 Cr | down ₹7 Cr | Trimmed |
| Procter & Gamble Health Limited | 3.32% | up 0.15 pts | ₹77.9 Cr | up ₹3.2 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.04% | up 0.28 pts | ₹71.3 Cr | up ₹6.4 Cr | Added |
| Alkem Laboratories Limited | 3.00% | down 0.06 pts | ₹70.4 Cr | down ₹1.6 Cr | Trimmed |
| Kovai Medical Center and Hospital Limited | 2.95% | up 0.32 pts | ₹69.1 Cr | up ₹7.3 Cr | Added |
| Intuitive Surgical Inc | 2.48% | down 0.18 pts | ₹58.1 Cr | down ₹4.4 Cr | Trimmed |
| Indoco Remedies Limited | 2.36% | down <0.01 pts | ₹55.3 Cr | down ₹29 L | Trimmed |
| Unichem Laboratories Limited | 1.84% | up 0.31 pts | ₹43.2 Cr | up ₹7 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 1.76% | up 0.03 pts | ₹41.3 Cr | up ₹63 L | Added |
| Narayana Hrudayalaya Limited | 1.64% | up 0.01 pts | ₹38.3 Cr | up ₹10 L | Held |
| Aarti Drugs Limited | 1.59% | up 0.23 pts | ₹37.2 Cr | up ₹5.2 Cr | Added |
| Taro Pharmaceutical Industries Limited | 1.35% | up 0.01 pts | ₹31.7 Cr | up ₹16 L | Added |
| Abbott Laboratories | 1.19% | down 0.08 pts | ₹28 Cr | down ₹2 Cr | Trimmed |
| Cash, TREPS & receivables | 1.01% | down 0.70 pts | ₹23.7 Cr | down ₹16.4 Cr | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 0.91% | down 0.14 pts | ₹21.3 Cr | down ₹3.3 Cr | Trimmed |
| Illumina Inc | 0.89% | down 0.10 pts | ₹21 Cr | down ₹2.4 Cr | Trimmed |
| MedPlus Health Services Limited | 0.57% | up 0.01 pts | ₹13.4 Cr | up ₹17 L | Added |
| Jupiter Life Line Hospitals Limited | 0.51% | up 0.02 pts | ₹11.9 Cr | up ₹36 L | Added |
| Pfizer Limited | 0.46% | up 0.01 pts | ₹10.8 Cr | up ₹16 L | Added |
What changed, Mar 2024 to Apr 2024
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- IPCA Laboratories Limitedup ₹16.4 Cr (+0.73% pts)
- Zydus Lifesciences Limitedup ₹15.7 Cr (+0.68% pts)
- Concord Biotech Limitedup ₹9.1 Cr (+0.40% pts)
- Kovai Medical Center and Hospital Limitedup ₹7.3 Cr (+0.32% pts)
- Unichem Laboratories Limited ₹7 Cr (+0.31% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2024, the weight rose most in Pharmaceuticals & Biotechnology (+0.2 pts) and Pharmaceuticals (+0.2 pts), and fell most in Healthcare Equipment & Supplies (−0.5 pts).
- Pharmaceuticals & Biotechnology71.3% → 71.6%+0.2 pts
- Pharmaceuticals5.3% → 5.5%+0.2 pts
- Healthcare Services13.9% → 14.0%+0.1 pts
- Healthcare Equipment & Supplies7.1% → 6.5%−0.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2021 | Apr 2023 | Oct 2023 | Jan 2024 | Mar 2024 | Apr 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 63.1% | 69.5% | 73.3% | 71.1% | 71.3% | 71.6% |
| Healthcare Services | 21.6% | 15.1% | 11.7% | 13.3% | 13.9% | 14.0% |
| Healthcare Equipment & Supplies | 5.4% | 6.4% | 6.3% | 7.3% | 7.1% | 6.5% |
| Pharmaceuticals | 6.9% | 5.7% | 5.8% | 6.0% | 5.3% | 5.5% |
| Insurance | 3.0% | 2.1% | 2.0% | 1.7% | 1.8% | 1.8% |
| Retailing | — | 1.2% | 0.9% | 0.6% | 0.6% | 0.6% |
Allocation in Apr 2024change vs Mar 2024
- Pharmaceuticals & Biotechnology (13)71.6%▲ 0.2 pts
- Healthcare Services (6)14.0%▲ 0.1 pts
- Healthcare Equipment & Supplies (2)6.5%▼ 0.5 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Apr 2024
1.0%
▼ 0.7 pts vs Mar 2024
- Cash alone
- 1.0%
- cash and net receivables
- A year earlier
- 0.2%
- Apr 2023 · now ▲ 0.8 pts
- Last 12 months
- 0.4% – 3.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.